Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 5/20 | 0.53 |
| ▸ | KISS1R | Q969F8 | 6/20 | 0.47 |
| ▸ | MC4R | P32245 | 3/20 | 0.44 |
| ▸ | PRKACB | P22694 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2197058 | 1.00 | GHSR (0.53) | GHSRKISS1RMC4RPRKACB | |
| SCHEMBL31001649 | 0.91 | GHSR (0.57) | GHSRKISS1RMC4R | |
| SCHEMBL31606511 | 0.88 | GHSR (0.59) | GHSRKISS1RMC4R | |
| SCHEMBL30866241 | 0.88 | GHSR (0.62) | GHSRKISS1RPRKACB | |
| SCHEMBL21570983 | 0.88 | GHSR (0.64) | GHSRKISS1RMC4RPRKACB | |
| SCHEMBL21570985 | 0.88 | GHSR (0.64) | GHSRKISS1RMC4RPRKACB | |
| SCHEMBL21570979 | 0.88 | GHSR (0.64) | GHSRKISS1RMC4RPRKACB | |
| SCHEMBL31026129 | 0.87 | GHSR (0.60) | GHSRKISS1R | |
| SCHEMBL30866231 | 0.87 | GHSR (0.57) | GHSRKISS1RMC4R | |
| SCHEMBL29895432 | 0.87 | GHSR (0.53) | GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9173951-B2 | Carbohydrate-based drug delivery polymers and conjugates thereof | NEKTAR THERAPEUTICS (US) | 2015-11-03 | — | — | US | disclosed |
| US-20150051371-A1 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF | NEKTAR THERAPEUTICS (US) | 2015-02-19 | — | — | US | disclosed |
| US-8680263-B2 | Carbohydrate-based drug delivery polymers and conjugates thereof | NEKTAR THERAPEUTICS (US) | 2014-03-25 | — | — | US | disclosed |
| US-20110171716-A1 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF | NEKTAR THERAPEUTICS (US) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110171716-A1 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF | STT3B, STT3A, DDOST | GHSR 1832/4885KISS1R 3907/4885MC4R 1805/4885 |
| US-20150051371-A1 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF | STT3B, STT3A, DDOST | GHSR 1832/4885KISS1R 3907/4885MC4R 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.